Home / Resource Library / Clinical outcomes of Japanese patients treated with out-of-specification tisagenlecleucel in a phase 3b trial

Clinical outcomes of Japanese patients treated with out-of-specification tisagenlecleucel in a phase 3b trial

Study investigated use of out of specification CAR-T for treatment of relapsed DLBCL.